HomeFUNDING

Category: FUNDING

Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.

Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.

E Tech Group Secures New...

April 11, 2024

With this new investment partnership, E Tech Group expects to accelerate organic growth and acquisition to become a top system integrator in North America.

ROM InWest Invests €1.5 million...

April 10, 2024

The investment will allow ROM InWest to further distribute its fall detection product globally.

E Tech Group Secures New Investment from Graham Partners, Sets Stage for Continued Growth and Innovation

April 11, 2024

With this new investment partnership, E Tech Group expects to accelerate organic growth and acquisition to become a top system integrator in North America.

Sigrid Therapeutics Secures $4 Million in Oversubscribed Funding Round to Tap Into Booming Obesity and Diabetes Market

Sigrid Therapeutics notes the funds will be instrumental in accelerating the commercialisation of SiPore® across diverse markets, including medical devices, food supplements, veterinary, and oral health.

October 31, 2023

Palatin Technologies Announces $5 Million Registered Direct Offering

Palatin Technologies is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential.

October 23, 2023

CIONIC Raises $12 Million Series A Extension Led by L Catterton with New Partners THVC and Enable Ventures

Nine months after the start of shipments, Cionic Neural Sleeve licensed nearly nationwide with more than 200,000 hours of customer use, transforming the lives of those with mobility impairments.The company expands the board with the addition of Whitney Casey, Venture Partner at L Catterton.

October 18, 2023

Akura Medical, a Shifamed Portfolio Company, Closes $35M in Series B Financing

Akura Medical reports the funds will be used to apply for FDA 510(k) clearance for the Akura Mechanical Thrombectomy Platform, support clinical trials for additional indications, and scale manufacturing capabilities.

October 3, 2023

Laverock Therapeutics Raises £13.5M

Laverock Therapeutics notes the funding will enable further development of the GEiGS technology and progression of Laverock’s programs in regenerative medicine and immuno-oncology, with a focus on Type I Diabetes and solid tumor responsive T-cell and macrophage-based immune therapies, through to in vitro and in vivo validation.

September 28, 2023

SpineX Receives NIH SBIR Phase II Award for SCiP Clinical Trial in Children With CP

These funds will go towards completing a pivotal clinical trial to test the efficacy and safety of our proprietary SCiP™ device in children living with Cerebral Palsy (CP) notes SpineX.

September 26, 2023

Summus Raises $19.5 Million

Fundraise supports market expansion with Summus emerging as the premier clinical platform to share and access high quality specialty expertise across the continuum of care — serving employers, payers, health systems and physician groups.

September 13, 2023

Thirona Raises €7,5 Million New Financing to Accelerate the Adoption of its Breakthrough Innovations for Precision Medicine

With this financing, Thirona plans to accelerate the adoption of its break-through innovations for precision medicine.

September 11, 2023

Levee Medical Secures $4.3M Strategic Investment to Accelerate Clinical Development of the Voro Urologic Scaffold, Designed to Improve Robotic Prostatectomy Outcomes

The trial will evaluate the safety and performance of the Voro Urologic Scaffold as a prophylactic treatment for post-prostatectomy stress urinary incontinence, notes Levee Medical.

September 6, 2023